Suchergebnisse - "Evans, Paul"

PubPharm (11)

1

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

enthalten in: Blood | 2022

von Tirtakusuma, R. | Szoltysek, K. | Milne, P. | +54

CommentIn: Blood. 2022 Oct 27;140(17):1833-1835. - PMID 36301633

2

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome

enthalten in: Blood | 2021

von Poulter, J. | Collins, J. | Cargo, C. | +12

CommentOn: N Engl J Med. 2020 Dec 31;383(27):2628-2638. - PMID 33108101

3

Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL

enthalten in: Blood | 2020

von Kwok, M. | Oldreive, C. | Rawstron, A. | +27

4

The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis

enthalten in: Blood | 2019

von Cargo, C. | Cullen, M. | Taylor, J. | +6

CommentIn: Blood. 2019 Mar 21;133(12):1271-1272. - PMID 30898774

5

Minimal residual disease is an independent predictor for 10-year survival in CLL

enthalten in: Blood | 2016

von Kwok, M. | Rawstron, A. | Varghese, A. | +6

CommentIn: Blood. 2016 Dec 15;128(24):2747-2748. - PMID 27979863

6

Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression

enthalten in: Blood | 2015

von Cargo, C. | Rowbotham, N. | Evans, P. | +4

CommentIn: Blood. 2015 Nov 19;126(21):2349-51. - PMID 26585803

7

Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression

enthalten in: Blood | 2015

von Cargo, C. | Evans, P. | Jack, A. | +4

8

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia : proof of principle in human volunteers

enthalten in: Blood | 2013

von Ghevaert, C. | Herbert, N. | Hawkins, L. | +11

CommentIn: Blood. 2013 Jul 18;122(3):303-4. - PMID 23869072

9

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers

enthalten in: Blood | 2013

von Ghevaert, C. | Herbert, N. | Hawkins, L. | +11

10

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity

enthalten in: Blood | 2006

von Armour, K. | Parry-Jones, D. | Beharry, N. | +10